In 2018, Open Source Pharma Foundation commenced operations in India with the philanthropic support of the Tata Trusts. OSPF's registered office and the OSPF NIAS Drug Discovery Lab are located in Bangalore.
Repurposing already-approved “off patent generic drugs” in order to rapidly and cost-effectively create new treatments and regimens against neglected infectious diseases, using open methodology conforming to standard regulatory endpoints. Future project. Funded by the India Health Fund.
A 3-center Phase 2b clinical trial of metformin, a generic diabetes drug, as an adjunct therapy for tuberculosis. Open IP, open data (once ready), and openly-available protocol published in open access academic journal. In partnership with the Government of India's National Institute for Research in Tuberculosis (NIRT).
Accumulating and analyzing traditional health care systems with modern tools.
An evolving project and discussion space for post graduates, researchers, and professional students who are passionate about solving problems in the health sector, particularly with a focus on neglected diseases.
Enabling low cost generic drugs to be used for other diseases on an affordable basis.
Peer-reviewed research papers have been published by members of the OSPF Bangalore scientific team and affiliated open researchers.
Conducting open source research to find possible cures for the fatal infection — for which there is currently no available treatment or vaccine.
Building an open, living, AI-powered, automatically updated knowledge base and knowledge graph focused on the specific content needed to enable drug discovery and development for TB, Chikungunya, and Nipah Virus. US operations funded by Wellcome Trust, UK. TB Knowledge Graph in partnership with Mayo Clinic Center for Tuberculosis. OSPF has partnered with Ingentium, Inc., to provide interactive knowledgebases and knowledgegraphs for TB, Chikungunya, and Nipah Virus.
The 50th Union World Conference on Lung Health, Hyderabad, India, 30 Oct – 2 Nov 2019. Theme: Ending the Emergency: Science, Leadership, Action. This meeting is the world's largest gathering of clinicians and public health workers, health programme managers, policymakers, researchers and advocates working to end the suffering caused by lung disease, including tuberculosis.
A collection of videos displayed as a quilt, contributed by people across the world sharing thoughts and experiences concerning tuberculosis, to raise awareness and bring the community together in support of those affected.
A series of workshops connecting women scientists through virtual labs, whittling down potential molecules that could eventually become drugs to fight diseases such as tuberculosis.
24 March 2018
Organised by OSPF students, 40+ interns, researchers, scientists and thought leaders; activities, workshops and presentations.
12 January 2018
“Open Source Model for Affordable Health Care and Wellbeing.”
11 August 2018
Training clinical practitioners from various disciplines to access research, identify problems, contribute scientific knowledge and support the drug discovery ecosystem.
UK and European Patent Attorney, Cleveland Scott York
“Intellectual Property as a Mechanism for Translating Research into Societal Benefits.”
In collaboration with TBInfo and NIAS, we have created a series of newsletters dedicated to tuberculosis.
The inaugural issue, with articles on what the COVID-19 pandemic can teach the fight against TB, bacteriophages as therapeutics for drug-resistant TB, and the TB endemic.
Opens with the 2021 World TB Day theme “The Clock is Ticking”, with articles on using COVID-19 innovations to reimagine TB care, shorter treatment regimens, and new vaccines.
Patient stories take centre stage — TB champions from across India share their journeys, alongside articles on vaccines and therapies and COVID-induced pulmonary fibrosis.
In partnership with the National Institute for Research in Tuberculosis in India, we have commenced a multicentric phase 2b clinical trial.
Learn MoreFor enquiries about our work in India, including partnerships, research collaborations and volunteering, please use our contact form.
Help advance open science through AI, global collaboration, and accessible healthcare. Volunteer or donate to make a lasting impact.
